MAITLAND, Fla., Feb. 9 /PRNewswire/ -- Scient’x USA, manufacturer of innovative spine implant technologies, today announced the receipt of 510K clearance to market their new Antelys GX® PEEK VBR System. The Antelys® GX System was developed to meet the technical and surgical requirements of lumbar arthrodesis for surgeons using an anterior surgical approach. Antelys GX® is an addition to the other PEEK VBR systems offered by Scient’x, including the Ellys, Corelys, Aurys, and Antelus VBR System.
Developed in conjunction with renowned surgeons led by Dr. Pasquale Montesand, the implant offers a smaller footprint to conform to the natural vertebral body anatomy, while still providing optimum contact area between the graft and the verebral endplates.
Timothy Seese, COO of Scient’x USA, indicated that the Antelys GX® PEEK Spacer was a direct result of surgeon requests for a smaller vertebral implant that would include a large variety of height and angles, as well as surgeon friendly instrumentation. “Scient’x is committed to meeting the needs of our surgeon community through our collaborative effort to bring innovative ideas for practical application,” said Mr. Seese.
Scient’x USA Inc. is a diversified spinal company that designs, manufactures, markets and distributes a comprehensive and innovative range of quality spinal devices. Based in Orlando, Florida, Scient’x USA offers a range of products to treat conditions such as lumbar instability, trauma, and degenerative disc disease. Scient’x USA has become known for producing and marketing the “Jsobar TTL Dynamic Spine Stabilization System” and continues to develop new products in conjunction with surgeon physicians for the Orthopaedic and Neurological community. For more information visit www.scientxusa.com.
Except for the historical information contained herein, the matters discussed are forward looking statements made pursuant to the safe harbor provisions of the private securities litigation form act of 1995. These statements involved risks and uncertainties, such as regulatory approvals, manufacturing uncertainties, the impacts of competitive products and pricing, and other risks and uncertainties set forth.
Source: Scient’x USA Inc.
